{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-005988","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.427026+00:00","generated_at":"2026-05-31T01:23:05.937462+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"VolitionRx enters CEO employment agreement with Dr. Michel for Belgian subsidiary; consulting fee amended","bullets":["Employment agreement with Dr. Gaetan Michel as CEO of Belgian Volition, effective Sept 1, 2024, with €12,000/month salary plus 13th month bonus.","Consulting agreement amendment with 3F Management SRL increases monthly fee to €15,598 from Nov 1, 2024; variable bonus up to €26,390.","Dr. Michel also serves as COO of parent, CEO of Volition America, and Manager of Volition Veterinary Diagnostics.","Combined aggregate annual compensation is materially consistent with prior arrangements."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-005988","json":"https://secwatch.observer/filing/0001477932-24-005988.json","markdown":"https://secwatch.observer/filing/0001477932-24-005988.md","text":"https://secwatch.observer/filing/0001477932-24-005988.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005988/0001477932-24-005988-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793224005988/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:23:05.937462+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}